BIONET is a prominent player in the bioprocess industry, offering a diverse range of cutting-edge laboratory, pilot, and industrial equipment along with state-of-the-art software solutions. With a strong focus on aiding biotech clients throughout the entirety of their R&D and industrial production phases, BIONET aims to enhance the productivity and profitability of bioprocesses. The company's product and service portfolio includes an array of bioreactors, TFF systems, industrial bioprocess skids, complete bioproduction lines, and automation solutions complemented by a suite of proprietary software. Additionally, BIONET provides specialized services facilitated by a team of experts, leveraging their pilot plant to unlock the full potential of clients' bioprocesses.
Founded in 1999, BIONET operates at the intersection of the Biotechnology and Industrial sectors, catering to the growing demand for innovative bioprocessing technology. Notably, the company's commitment to quality is deeply embedded in its corporate culture, operating within a fully documented engineering environment and offering units in GMP version (and CFR 21.c 11) to ensure compliance with industry standards.
There is no investment information
No recent news or press coverage available for BIONET.